Skip to main navigation
Skip to search
Skip to main content
The University of Aberdeen Research Portal Home
Help & FAQ
Home
Profiles
Disciplines
Research output
Research Facilities
Datasets
Impacts
Activities
Press/Media
Prizes
Projects
Search by expertise, name or affiliation
Reslizumab for pediatric eosinophilic esophagitis
Garry Michael Walsh
Applied Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Reslizumab for pediatric eosinophilic esophagitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
reslizumab
100%
Eosinophilic Esophagitis
77%
Eosinophils
52%
Interleukin-5
40%
Pediatrics
35%
Antibodies, Monoclonal, Humanized
23%
Esophagus
17%
Gastrointestinal Tract
15%
Mucous Membrane
14%
Bone Marrow
13%
Skin
10%
Therapeutics
5%